UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Synthetic data use: exploring use cases to optimise data utility

Discover Artificial Intelligence, 2021-12, Vol.1 (1), p.1-13, Article 15

2021

Volltextzugriff (PDF)

Protecting patient privacy when sharing patient-level data from clinical trials

BMC medical research methodology, 2016-07, Vol.16 Suppl 1 (Suppl 1), p.77-77, Article 77

2016

Volltextzugriff (PDF)

Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations

Trials, 2020-02, Vol.21 (1), p.200-200, Article 200

2020

Volltextzugriff (PDF)

EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers

BMC medical research methodology, 2016-07, Vol.16 Suppl 1 (Suppl 1), p.73-73, Article 73

2016

Volltextzugriff (PDF)

Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

BMC medical research methodology, 2021-11, Vol.21 (1), p.1-250, Article 250

2021

Volltextzugriff (PDF)

Best practice for analysis of shared clinical trial data

BMC medical research methodology, 2016-07, Vol.16 Suppl 1 (Suppl 1), p.76-76, Article 76

2016

Volltextzugriff (PDF)

Democratizing data at Novartis through clinical trial data access

Drug discovery today, 2022-06, Vol.27 (6), p.1533-1537

2022

Volltextzugriff (PDF)

Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials

Statistics in biopharmaceutical research, 2020-10, Vol.12 (4), p.419-426

2020

Volltextzugriff (PDF)

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056

Science translational medicine, 2011-01, Vol.3 (64), p.64ra1

2011

Volltextzugriff (PDF)

Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable

Nature reviews. Drug discovery, 2024-09, Vol.23 (9), p.645-646

2024

Volltextzugriff (PDF)

Good Data Science Practice: Moving Toward a Code of Practice for Drug Development

Statistics in biopharmaceutical research, 2023-01, Vol.15 (1), p.74-85

2023

Volltextzugriff (PDF)

Good Data Science Practice: Moving toward a Code of Practice for Drug Development (Rejoinder)

Statistics in biopharmaceutical research, 2023-01, Vol.15 (1), p.89-91

2023

Volltextzugriff (PDF)

Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients

The Annals of pharmacotherapy, 2004-10, Vol.38 (10), p.1582-1587

2004

Volltextzugriff (PDF)

Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework

Therapeutic innovation & regulatory science, 2024-05, Vol.58 (3), p.495-504

2024

Volltextzugriff (PDF)

Addressing Food Insecurity in Food Deserts for Children Through Container Gardening

Journal of family and consumer sciences, 2021-12, Vol.113 (4), p.16-22

2021

Volltextzugriff (PDF)

Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: an integrated study

Clinical gastroenterology and hepatology, 2004-02, Vol.2 (2), p.113-120

2004

Volltextzugriff (PDF)

Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy

Pharmaceutical research, 2004-03, Vol.21 (3), p.443-446

2004

Volltextzugriff (PDF)

A Graphical Approach for Incorporating Prior Knowledge When Determining a Sample Size for the Assessment of Batched Products

Journal of the Royal Statistical Society. Series D (The Statistician), 2001-01, Vol.50 (4), p.417-426

2001

Volltextzugriff (PDF)

Soil genesis and classification in the Whiteoak Mountain fault block in east Tennessee

Branson, Janice L

1998

Volltextzugriff (PDF)

SURVEYING PERCHED WATER ON ANTHROPOGENIC SOILS USING NONINTRUSIVE IMAGERY

Transactions of the ASAE, 2001, Vol.44 (6)

2001

Volltextzugriff (PDF)

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial

JAMA : the journal of the American Medical Association, 2015-02, Vol.313 (5), p.471

2015

Volltextzugriff (PDF)

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial

Annals of emergency medicine, 2019-06, Vol.73 (6), p.650-661

2019

Volltextzugriff (PDF)

Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial

Journal of the American College of Surgeons, 2018-12, Vol.227 (6), p.587-595

2018

Volltextzugriff (PDF)

Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)

JPEN. Journal of parenteral and enteral nutrition, 2009-05, Vol.33 (3), p.277-316

2009

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(35)
Dissertationen
(1)

Sprache

Englisch
(36)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Synthetic data use: exploring use cases to optimise data utility

Protecting patient privacy when sharing patient-level data from clinical trials

Evaluating the re-identification risk of a clinical study report anonymized under EMA Policy 0070 and Health Canada Regulations

EFSPI/PSI working group on data sharing: accessing and working with pharmaceutical clinical trial patient level datasets - a primer for academic researchers

Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

Best practice for analysis of shared clinical trial data

Democratizing data at Novartis through clinical trial data access

Challenges in Assessing the Impact of the COVID-19 Pandemic on the Integrity and Interpretability of Clinical Trials

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056

Data science in pharmaceutical R&D: the DISRUPT-DS industry roundtable

Good Data Science Practice: Moving Toward a Code of Practice for Drug Development

Good Data Science Practice: Moving toward a Code of Practice for Drug Development (Rejoinder)

Lumiracoxib does not affect methotrexate pharmacokinetics in rheumatoid arthritis patients

Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework

Addressing Food Insecurity in Food Deserts for Children Through Container Gardening

Pharmacology and gastrointestinal safety of lumiracoxib, a novel cyclooxygenase-2 selective inhibitor: an integrated study

Assessment of lumiracoxib bioavailability from targeted sites in the human intestine using remotely activated capsules and gamma scintigraphy

Antagonism of mGluR5 in Fragile X: A Randomized, Placebo-Controlled, Proof-of-Concept Study of AFQ056, a Novel, Sub-Type Selective mGluR5 Antagonist

A Graphical Approach for Incorporating Prior Knowledge When Determining a Sample Size for the Assessment of Batched Products

Soil genesis and classification in the Whiteoak Mountain fault block in east Tennessee

SURVEYING PERCHED WATER ON ANTHROPOGENIC SOILS USING NONINTRUSIVE IMAGERY

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial

Older Blood Is Associated With Increased Mortality and Adverse Events in Massively Transfused Trauma Patients: Secondary Analysis of the PROPPR Trial

Elevated Syndecan-1 after Trauma and Risk of Sepsis: A Secondary Analysis of Patients from the Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) Trial

Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)

Suchergebnisse filtern